48 related articles for article (PubMed ID: 34859284)
21. Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Axcrona U; Abolhasani M; Rasti A; Asgari M; Fodstad Ø; Andersson Y
Ann Diagn Pathol; 2020 Jun; 46():151483. PubMed ID: 32143173
[TBL] [Abstract][Full Text] [Related]
22. Targeting the HIF2-VEGF axis in renal cell carcinoma.
Choueiri TK; Kaelin WG
Nat Med; 2020 Oct; 26(10):1519-1530. PubMed ID: 33020645
[TBL] [Abstract][Full Text] [Related]
23. The specificity of thioredoxins and glutaredoxins is determined by electrostatic and geometric complementarity.
Berndt C; Schwenn JD; Lillig CH
Chem Sci; 2015 Dec; 6(12):7049-7058. PubMed ID: 29861944
[TBL] [Abstract][Full Text] [Related]
24. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
Liu J; Lichtenberg T; Hoadley KA; Poisson LM; Lazar AJ; Cherniack AD; Kovatich AJ; Benz CC; Levine DA; Lee AV; Omberg L; Wolf DM; Shriver CD; Thorsson V; ; Hu H
Cell; 2018 Apr; 173(2):400-416.e11. PubMed ID: 29625055
[TBL] [Abstract][Full Text] [Related]
25. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
[TBL] [Abstract][Full Text] [Related]
26. Systemic Therapy for Metastatic Renal-Cell Carcinoma.
Choueiri TK; Motzer RJ
N Engl J Med; 2017 Jan; 376(4):354-366. PubMed ID: 28121507
[No Abstract] [Full Text] [Related]
27. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
Zhao M; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 as an emerging regulator of renal cell cancer.
Kamińska K; Czarnecka AM; Escudier B; Lian F; Szczylik C
Urol Oncol; 2015 Nov; 33(11):476-85. PubMed ID: 26296264
[TBL] [Abstract][Full Text] [Related]
29. Redox regulation by glutathione needs enzymes.
Berndt C; Lillig CH; Flohé L
Front Pharmacol; 2014; 5():168. PubMed ID: 25100998
[No Abstract] [Full Text] [Related]
30. Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α.
Kroeger N; Seligson DB; Signoretti S; Yu H; Magyar CE; Huang J; Belldegrun AS; Pantuck AJ
Eur J Cancer; 2014 May; 50(8):1531-40. PubMed ID: 24565854
[TBL] [Abstract][Full Text] [Related]
31. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.
Hanschmann EM; Godoy JR; Berndt C; Hudemann C; Lillig CH
Antioxid Redox Signal; 2013 Nov; 19(13):1539-605. PubMed ID: 23397885
[TBL] [Abstract][Full Text] [Related]
32. IGFBP-3 nuclear localization predicts human prostate cancer recurrence.
Seligson DB; Yu H; Tze S; Said J; Pantuck AJ; Cohen P; Lee KW
Horm Cancer; 2013 Feb; 4(1):12-23. PubMed ID: 23011725
[TBL] [Abstract][Full Text] [Related]
33. Redox atlas of the mouse. Immunohistochemical detection of glutaredoxin-, peroxiredoxin-, and thioredoxin-family proteins in various tissues of the laboratory mouse.
Godoy JR; Funke M; Ackermann W; Haunhorst P; Oesteritz S; Capani F; Elsässer HP; Lillig CH
Biochim Biophys Acta; 2011 Jan; 1810(1):2-92. PubMed ID: 20682242
[TBL] [Abstract][Full Text] [Related]
34. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.
Nickerson ML; Jaeger E; Shi Y; Durocher JA; Mahurkar S; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Mukeria A; Holcatova I; Schmidt LS; Toro JR; Karami S; Hung R; Gerard GF; Linehan WM; Merino M; Zbar B; Boffetta P; Brennan P; Rothman N; Chow WH; Waldman FM; Moore LE
Clin Cancer Res; 2008 Aug; 14(15):4726-34. PubMed ID: 18676741
[TBL] [Abstract][Full Text] [Related]
35. Thioredoxin and related molecules--from biology to health and disease.
Lillig CH; Holmgren A
Antioxid Redox Signal; 2007 Jan; 9(1):25-47. PubMed ID: 17115886
[TBL] [Abstract][Full Text] [Related]
36. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.
Raval RR; Lau KW; Tran MG; Sowter HM; Mandriota SJ; Li JL; Pugh CW; Maxwell PH; Harris AL; Ratcliffe PJ
Mol Cell Biol; 2005 Jul; 25(13):5675-86. PubMed ID: 15964822
[TBL] [Abstract][Full Text] [Related]
37. Tissue microarrays for high-throughput molecular profiling of tumor specimens.
Kononen J; Bubendorf L; Kallioniemi A; Bärlund M; Schraml P; Leighton S; Torhorst J; Mihatsch MJ; Sauter G; Kallioniemi OP
Nat Med; 1998 Jul; 4(7):844-7. PubMed ID: 9662379
[TBL] [Abstract][Full Text] [Related]
38. Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC.
Ribback S; Winter S; Klatte T; Schaeffeler E; Gellert M; Stühler V; Scharpf M; Bedke J; Burchardt M; Schwab M; Lillig CH; Kroeger N
World J Urol; 2022 Mar; 40(3):739-746. PubMed ID: 34859284
[TBL] [Abstract][Full Text] [Related]
39. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
[TBL] [Abstract][Full Text] [Related]
40. Thioredoxin promotes survival signaling events under nitrosative/oxidative stress associated with cancer development.
Monteiro HP; Ogata FT; Stern A
Biomed J; 2017 Aug; 40(4):189-199. PubMed ID: 28918907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
